Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-blockade, atrial natriuretic peptide and exercise

I Kantola1, L Tarssanen, M Scheinin

  • 1Department of Medicine, University of Turku, Finland.

International Journal of Clinical Pharmacology and Therapeutics
|January 1, 1996
PubMed
Summary

Beta-blockers like atenolol, propranolol, and pindolol minimally impact atrial natriuretic peptide (ANP) and vasopressin (VP) release during exercise. Pindolol

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional cofactor dyxin mediates hypertrophic response in the heart during angiotensin II-induced hypertension.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2024
Same author

Self-monitoring of Blood Pressure in Patients With Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis.

American journal of hypertension·2019
Same author

Effects of vatinoxan on cardiorespiratory function, fecal output and plasma drug concentrations in horses anesthetized with isoflurane and infusion of medetomidine.

Veterinary journal (London, England : 1997)·2019
Same author

Effects of vatinoxan on cardiorespiratory function and gastrointestinal motility during constant-rate medetomidine infusion in standing horses.

Equine veterinary journal·2019
Same author

Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model.

Veterinary journal (London, England : 1997)·2018
Same author

Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality.

Journal of internal medicine·2018

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pharmacology

Background:

  • Beta-adrenoceptor blocking therapy outcomes may be influenced by atrial natriuretic peptide (ANP) and vasopressin (VP) release.
  • Understanding the effects of different beta-blockers on these hormones is crucial for optimizing therapeutic strategies.

Purpose of the Study:

  • To investigate the impact of atenolol, propranolol, and pindolol on plasma ANP and VP levels during exercise in healthy volunteers.
  • To compare the beta-adrenoceptor antagonism and agonism profiles of these beta-blockers in relation to hormonal responses.

Main Methods:

  • A randomized, double-blind, placebo-controlled crossover study involving 15 healthy volunteers.
  • Administration of atenolol, propranolol, or pindolol prior to a 30-minute bicycle exercise test.

Related Experiment Videos

  • Measurement of plasma ANP, VP, adrenaline, and noradrenaline concentrations to assess hormonal release and sympathoadrenal activation.

    • Main Results:

    • All beta-blockers and placebo similarly increased plasma ANP levels during exercise.
    • Pindolol administration enhanced the decline of plasma ANP post-exercise and increased mean plasma VP levels.
    • Differences in beta 1- and beta 2-adrenoceptor occupancy were observed among the agents.

    Conclusions:

    • Beta 1- and beta 2-antagonism by pindolol, atenolol, and propranolol do not significantly alter plasma ANP and VP responses to physical exercise.
    • Pindolol's beta-agonist activity may subtly influence these hormonal responses.
    • Hormonal changes during exercise are minimally affected by common beta-blocker therapies.